Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,063,337
+$5,001,861 QoQ
Shares Held
669,375
-1.3% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 625 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,063,337 | 669,375 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,061,476 | 678,043 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,590,935 | 779,768 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $8,670,449 | 811,840 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,094,714 | 836,231 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $11,813,651 | 793,395 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,919,840 | 798,917 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,221,701 | 795,698 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $16,316,939 | 788,258 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $14,938,254 | 794,588 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $11,548,718 | 800,882 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $10,393,917 | 598,728 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,893,914 | 1,388,463 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,422,319 | 1,421,017 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,167,758 | 1,473,962 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $37,374,081 | 1,597,183 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $61,226,246 | 1,814,111 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $61,648,165 | 1,764,906 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $41,455,634 | 1,361,433 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $43,975,061 | 1,341,112 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $69,961 | 2,312 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||